Startup · $9.3m raised
Digital therapeutics company developing the Confidanz Smart Patch for overactive bladder and urge urinary incontinence
Every investor coverage indicates participated in a round Australis Scientific raised.
| Investor | Rounds | Invested |
|---|---|---|
| Rohto Pharmaceutical | Unnamed stage | - |
Companies Australis Scientific acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Nicky Agahari | Founder, Chairman and CEO | ANDHealth, Startup Daily, SmartCompany |
Stories naming Australis Scientific. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
ANDHealth's blog interviews Australis Scientific's founder about its wearable therapy for bladder conditions, its years in ANDHealth programs, and plans to scale the device at home and abroad.
ANDHealth+ selected five Australian digital and connected health companies to receive tranched, milestone-based non-dilutive funding across two stages totalling up to $9 million.
Funding roundup covering four raises: Pay.com.au's $25 million round plus a $28 million secondary, Ruminant Biotech's Series A, Australis Scientific's Rohto-backed funding, and Paperly's $3 million round led by Tribe Global Ventures.